Pfizer To Acquire Blood Disorder Drugmaker Global Blood Therapeutics For $5.4B
Pfizer Inc. (NYSE:PFE) has reached an agreement to acquire Global Blood Therapeutics Inc (NASDAQ:GBT) in a deal with $5.4 billion.
Stay updated with breaking news from Dear Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer Inc. (NYSE:PFE) has reached an agreement to acquire Global Blood Therapeutics Inc (NASDAQ:GBT) in a deal with $5.4 billion.
There has become an increasing need for electric cars on the market – and, surprisingly enough, it may not just be tied in to increasing gas prices and care for the environment.
Efforts were made to revive the child stimulus check, but none materialized. One more effort was made last week by Sen. Bernie Sanders.
The U.S. Senate’s passing of a sweeping $430 billion bill to help fight climate change underscores why "every investor needs exposure" to ESG investments to build wealth over the long-term
Shares of Tyson Foods (NYSE:TSN) are down more than 9.0% in the wake of the Q2 earnings report and offering a discount to investors.